Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
8.01
-0.40 (-4.76%)
At close: Aug 15, 2025, 3:59 PM
8.08
0.87%
After-hours: Aug 15, 2025, 06:49 PM EDT
-4.76% (1D)
| Bid | 7.54 |
| Market Cap | 714.23M |
| Revenue (ttm) | -249K |
| Net Income (ttm) | -187.6M |
| EPS (ttm) | -2.49 |
| PE Ratio (ttm) | -3.22 |
| Forward PE | -5.35 |
| Analyst | Buy |
| Ask | 8.49 |
| Volume | 653,203 |
| Avg. Volume (20D) | 1,434,059 |
| Open | 8.43 |
| Previous Close | 8.41 |
| Day's Range | 7.92 - 8.43 |
| 52-Week Range | 2.04 - 8.72 |
| Beta | -0.45 |
About AMLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.51%
Amylyx Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+4.73%
Amylyx Pharmaceuticals shares are trading higher after Leerink Partners upgraded the stock from Market Perform to Outperform and raised its price target from $4 to $10.
